Oncternal Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Oncternal Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2018 to Q2 2024.
  • Oncternal Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $412K, a 24.1% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $412K +$80K +24.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $412K +$97K +30.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $412K -$862K -67.7% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $412K -$846K -67.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $332K -$57K -14.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $315K -$76K -19.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $1.27M +$617K +93.9% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $1.26M +$601K +91.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $389K -$269K -40.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $391K -$378K -49.2% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $657K -$109K -14.2% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $657K -$109K -14.2% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $658K -$108K -14.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $769K -$278K -26.6% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $766K -$1K -0.13% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $766K -$2K -0.26% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $766K -$1K -0.13% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.05M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $767K +$15K +2% Dec 31, 2019 10-K/A 2021-03-12
Q3 2019 $768K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $767K Jun 30, 2019 10-Q 2019-08-09
Q4 2018 $752K Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.